|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.090 USD | +0.98% |
|
-1.59% | -15.57% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
| Market Cap | 103M 90.12M 82.96M 77.3M 146M 9.76B 149M 998M 387M 4.79B 385M 377M 16.67B | P/E 2026 * |
1.29x | P/E 2027 * | 6.12x |
|---|---|---|---|---|---|
| Enterprise Value | 103M 90.12M 82.96M 77.3M 146M 9.76B 149M 998M 387M 4.79B 385M 377M 16.67B | EV / Sales 2026 * |
1.29x | EV / Sales 2027 * | 0.77x |
| Free-Float |
77.21% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fortress Biotech, Inc.
| 1 day | +0.98% | ||
| 1 week | -1.59% | ||
| Current month | +0.98% | ||
| 1 month | +20.23% | ||
| 3 months | +25.10% | ||
| 6 months | -15.57% | ||
| Current year | -15.57% |
| 1 week | 2.7 |  | 3.12 |
| 1 month | 2.59 | | 3.35 |
| Current year | 2.18 | | 4.53 |
| 1 year | 1.77 | | 4.53 |
| 3 years | 1.24 | | 10.35 |
| 5 years | 1.24 | | 57.15 |
| 10 years | 1.24 | | 91.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 19/12/2013 | |
Xiao Qin Lu
DFI | Director of Finance/CFO | 51 | 21/02/2012 |
David Jin
DFI | Director of Finance/CFO | 36 | 15/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jimmie Harvey
BRD | Director/Board Member | 74 | 30/11/2008 |
| Chairman | 71 | 19/12/2013 | |
J. Lobell
BRD | Director/Board Member | 63 | 31/05/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-21 | Free | Chief Financial Officer | 400,000 | 1.2041% | ||
| 03-31 | Free | Chief Financial Officer | 2,967 | 0.0096% | ||
| 03-17 | Free | Chief Executive Officer | 475,424 | 1.5318% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | -1.59% | +69.78% | -62.55% | 102M | |
| +0.19% | +0.21% | +16.79% | -13.06% | 63.44B | |
| -1.56% | +1.14% | +54.57% | +217.61% | 56.98B | |
| +0.36% | +39.60% | +39.60% | +39.60% | 41.58B | |
| +0.17% | +2.94% | -50.31% | -57.33% | 38.01B | |
| -2.93% | +5.09% | +61.25% | -26.37% | 31.9B | |
| +3.53% | +19.99% | +152.70% | -40.33% | 27.79B | |
| +0.40% | +4.93% | +65.59% | +82.83% | 22.65B | |
| -0.56% | +2.12% | +1.53% | +168.92% | 17.64B | |
| +1.34% | -0.64% | +64.17% | +122.53% | 16.49B | |
| Average | +0.25% | +3.77% | +47.57% | +43.19% | 31.66B | |
| Weighted average by Cap. | +0.05% | +3.19% | +40.06% | +50.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.88M 70.13M 64.55M 60.15M 113M 7.59B 116M 776M 301M 3.73B 300M 293M 12.97B | 134M 118M 108M 101M 191M 12.75B 194M 1.3B 505M 6.26B 504M 493M 21.79B |
| Net income | 90.51M 79.47M 73.15M 68.16M 129M 8.61B 131M 880M 341M 4.22B 340M 332M 14.7B | 21.13M 18.55M 17.08M 15.91M 30.01M 2.01B 30.62M 205M 79.58M 986M 79.34M 77.62M 3.43B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/07/26 | US$3.090 | +0.98% | 254,656 |
| 30/06/26 | US$3.060 | +3.73% | 490,825 |
| 29/06/26 | US$2.950 | +6.88% | 534,783 |
| 26/06/26 | US$2.760 | -8.61% | 1,103,740 |
| 25/06/26 | US$3.020 | -3.82% | 574,922 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- FBIO Stock
Select your edition
All financial news and data tailored to specific country editions
